Purpose
to develop a bivalent vaccine by conjugating a fusion of three novel, highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhoid
Grantee
Division
Global Health
Date
MARCH 2012
Region served
GLOBAL
Committed amount
$3,026,212
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology,
Pneumonia & Pandemic Preparedness
Duration (months)
114
Grantee location
Boston, Massachusetts, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.